About
Team
Portfolio
Insights
About
Team
Portfolio
Insights
Biopharmaceutical company focused on developing treatments for rare diseases
Biopharmaceutical company focused on developing treatments for rare diseases
Sectors
Healthcare
Life Sciences
First Invested
2015
Early
Company Status
IPO/Acquired
NASDAQ: CMTA
Acquired by Ipsen
Website
Clementia